| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Polycystic ovary syndrome | 225 | 22 | |
| Birth control | 71 | 35 | |
| Endometriosis | 31 | 10 | |
| Premenstrual dysphoric disorder | 17 | 3 | |
| Irregular menstrual periods | 8 | 8 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Weight gain | 15 | |
| Depressed mood | 7 | |
| Decreased sex drive (libido) | 6 | |
| Irregular menstrual periods | 4 | |
| Mood swings | 4 | |
| Vaginal dryness | 3 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 23 | |
| Moderate | 24 | |
| Mild | 22 | |
| None | 47 |
Member evaluations
COOPERATI
evaluated on May 09, 2017
- Perceived effectiveness for effects hormone levels: Moderate
- Side effects: Moderate
aquarianrose
evaluated on Mar 13, 2015
- Perceived effectiveness for irregular menstrual periods: Moderate
- Side effects: None
sunnyday
evaluated on Jul 01, 1993
- Perceived effectiveness for endometriosis: Slight
- Side effects: None